- Home
- KYTX vs STRS Comparison
KYTX vs STRS Comparison
Compare KYTX & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- STRS
- Stock Information
- Founded
- KYTX 2018
- STRS 1992
- Country
- KYTX United States
- STRS United States
- Employees
- KYTX N/A
- STRS N/A
- Industry
- KYTX
- STRS Homebuilding
- Sector
- KYTX
- STRS Real Estate
- Exchange
- KYTX NYSE
- STRS Nasdaq
- Market Cap
- KYTX 242.1M
- STRS 202.0M
- IPO Year
- KYTX 2024
- STRS N/A
- Fundamental
- Price
- KYTX $5.29
- STRS $26.40
- Analyst Decision
- KYTX Buy
- STRS
- Analyst Count
- KYTX 4
- STRS 0
- Target Price
- KYTX $23.25
- STRS N/A
- AVG Volume (30 Days)
- KYTX 262.9K
- STRS 8.4K
- Earning Date
- KYTX 11-15-2024
- STRS 11-15-2024
- Dividend Yield
- KYTX N/A
- STRS N/A
- EPS Growth
- KYTX N/A
- STRS N/A
- EPS
- KYTX N/A
- STRS N/A
- Revenue
- KYTX N/A
- STRS $42,935,000.00
- Revenue This Year
- KYTX N/A
- STRS N/A
- Revenue Next Year
- KYTX N/A
- STRS N/A
- P/E Ratio
- KYTX N/A
- STRS N/A
- Revenue Growth
- KYTX N/A
- STRS 31.68
- 52 Week Low
- KYTX $4.40
- STRS $20.30
- 52 Week High
- KYTX $30.60
- STRS $30.66
- Technical
- Relative Strength Index (RSI)
- KYTX 49.62
- STRS 60.21
- Support Level
- KYTX $4.78
- STRS $21.50
- Resistance Level
- KYTX $5.61
- STRS $27.77
- Average True Range (ATR)
- KYTX 0.36
- STRS 0.97
- MACD
- KYTX 0.06
- STRS 0.55
- Stochastic Oscillator
- KYTX 57.45
- STRS 78.15
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations.